Company has taken up a major expansion plans involving an investment of Rs.75 crores over a period of next 18 months which includes setting up a R&D center & Pilot Plant as per the FDA standards . Most of these projects are at an advanced stage of implementation. In addition the Company's existing facilities are being upgraded to meet the FDA standards .
To know about our Formulation
Division, please visit us at Ind-Swift
Limited, our other group company.